"GERD devices market to exhibit dynamic growth during the forecast period"
The global GERD devices market is growing proficiently, expected to grow at a CAGR of 3.7%. GERD is a common disease with the highest prevalence in North America. A recent study from the U.S. revealed that prevalence of gastroesophageal reflux disease ranged from 18% to 27% in North America, 8% to 25% in Europe, 8% to 30% in the Middle East, 2% to 7% in Asia, and around 22% in Latin America. High prevalence for complicated gastroesophageal reflux disease in the U.S. along with increasing rate of obesity and lifestyle disorders will drive market growth. The increasing demand in the diagnostic centers will grow significantly. Ageing population, new technology assessment in treatment devices, FDA approval, increasing endoscopy procedures and rising incidences of chronic diseases will drive the overall growth of GERD devices market on a global scale.
"Diagnostic devices expected to capture a larger market share by 2034"
Advancement in treatment devices and diagnostics segment along with technological advancement will drive the market growth. Chronic disease management along with improved cost savings and higher positive outcomes are key factors driving the overall growth of GERD devices. By type, presently, esophagoscopes and gastroscopes, generated maximum revenue share in the GERD devices market. The diagnostic devices cover pH monitoring devices and esophageal manometry systems.
"Increasing need for diagnosis in hospitals and diagnostic centers will show promising growth"
A recent study by Richter and a Gallup Organization National Survey, in the U.S. the prevalence rate of symptomatic GERD is estimated to be around 25-40%. Furthermore, approximately 7-9% of the mature population in the U.S. experience such kind of symptoms on a daily basis. Incidences are high among the adult population, few disease indication include erosive esophagitis, Barrett’s esophagus, stricture, adenocarcinoma and others both for nonerosive reflux disease patients and complicated GERD patients.
Hospitals in the end-user segment generated maximum revenue in the global market. The utilization of top end devices is gaining traction in the diagnostic centers. Increased lifestyle diseases along with check-ups for heartburn and/or regurgitation symptoms will boost the overall market growth. Advancement in sphincter augmentation devices, RF devices, ultrasonic devices and fundoplication GERD devices will further spur revenue growth in the end user segment globally.
"Increasing adult population, launch of new devices and the presence of top manufacturers holds the U.S. market in dominant position"
GERD is found to be more prevalent in the United States and Europe. In 2022, the United States produced maximum revenue in the GERD market due to an increase in prevalence for chronic diseases, growing hospital admissions for diagnostics/surgery, and increased need for fundoplication procedures and RF thermal ablation procedures. North America region generated about 40% revenue share worldwide, increasing at a CAGR of 3.1% from 2026-2034. Major risk factors investigated for GERD include lifestyle factors such as smoking, dietary habits, consumption of carbonated drinks, alcoholic beverages, and tobacco. Currently, advancement in minimally invasive surgical procedures along with therapy will drive the market growth in the U.S., introduction of advanced tools and devices will expand the services globally. For e.g. LINX magnetic system, EsophyX device, Stretta System device and others.
In the Asian countries and Latin America, increasing hospital infrastructure along with multispecialty diagnostic centers with improved treatment options will drive the overall growth of the market. The overall prevalence rate is increasing from 1.5 to 3% in the Asian countries, recent studies have shown that there is an increase in diagnostic procedures in countries such as Japan, South Korea, Indonesia, the Philippines, and Singapore. Moreover, a few studies from India also indicate a prevalence of 7.0 - 18.0%. However, high cost of surgical procedures, less adoption of top quality devices, economic constraints, less product expansion along with clinical outcomes, and unstructured reimbursement scenario in few of the emerging nations are few of the limiting factors on a global scale.
Key Industry Developments
List of Companies Covered:
Historical & Forecast Period
This study report represents analysis of each segment from 2024 to 2034 considering 2025 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2026 to 2034.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Gastroesophageal Reflux Disease (GERD) Devices market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2024-2034 |
| Base Year | 2025 |
| Forecast Period | 2026-2034 |
| Historical Year | 2024 |
| Unit | USD Million |
| Segmentation | |
Product
|
|
Procedure
|
|
End User
|
|
|
Region Segment (2024-2034; US$ Million)
|
Key questions answered in this report
